Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
about
Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal womenLHRH agonists for adjuvant therapy of early breast cancer in premenopausal womenAdjuvant Gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal womenDenosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsMenopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solutionChemotherapy- and irradiation-induced bone loss in adults with solid tumorsPrevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agentsHow do chemotherapeutic agents damage the ovary?Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic reviewOptimizing adjuvant therapy and survivorship care of stage III colon cancer.A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancerIncidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: design of a multicenter trial.GnRH agonist therapy to protect ovarian function in young Korean breast cancer patientsA multidimensional scale to measure the reproductive concerns of young adult female cancer survivors.Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivorsCurrent state and controversies in fertility preservation in women with breast cancer.Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Is Fatigue a Long-term Side Effect of Breast Cancer Treatment?The best of both worlds - managing the cancer, saving the bone.Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns.Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study.Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.Preserving fertility in patients undergoing treatment for breast cancer: current perspectives.Maintaining fertility in young women with breast cancer.Association of intrauterine and early-life exposures with age at menopause in the Sister Study.Incidence of chemotherapy-induced amenorrhea after adjuvant chemotherapy with taxane and anthracyclines in young patients with breast cancerLocal therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.Young breast cancer survivors: their perspectives on treatment decisions and fertility concerns.Fertility preservation in breast cancer patients.Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapyA vision for the future?The potential of ovarian tissue transplant to preserve fertility.Challenges in the gynecologic care of premenopausal women with breast cancer.Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal womenOvarian xenobiotic biotransformation enzymes are altered during phosphoramide mustard-induced ovotoxicity.Clinical cases in oncofertilityMenstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.
P2860
Q24235150-755FB9E1-8801-4FB7-BDF6-9855CD1DCE3DQ24240015-46A979B1-EF65-4A28-BCD3-33CD625BF8B2Q24241143-FB127C77-D87F-453B-9BCC-CE2DBA847B0CQ26824762-0FC244F8-9682-4736-977C-97D6B49E5F55Q27025094-18557430-C2AE-4F00-82BA-5C8CA3FAD034Q28084019-A3C18F3B-E332-4A51-BE19-42F1DF233EA5Q28240178-B51ED834-E059-4976-98BC-D70292679E22Q28267696-60C162CE-BE10-4CA3-B8A0-2FA73DCBCD93Q28384104-F9556C44-8D33-4850-9851-CC9156B72954Q30249616-6AD95991-64E5-4AD4-AEEE-B0CAF1FD2056Q30435881-2A3DD1AA-CDA3-4A59-8D50-5D578CB2334EQ33320772-E8B10E52-2323-4CBA-AA19-52A9ADF503A2Q33461959-7F06A8F2-ABDA-40D5-86B6-527524555346Q33565544-39824CFE-081C-4407-BB97-45DD762011CCQ33590794-01E21E94-B2CC-4978-8EDB-878445C0EA13Q33601886-4C706A1D-ED24-46B0-BE31-01DBDA092B5CQ33624886-768CC7C7-84C7-4F97-BD6B-DD2410656D7BQ33779879-14AC1FE9-6CAC-4201-8E32-AF225F3F8A64Q33838766-A474B035-9E94-4C4D-99CC-5D03E3BF66BDQ33887624-E5065C4E-93C4-4C8C-BA89-6348A1149061Q33920055-3FD76661-79AB-4750-B659-2AA931A1B210Q33926595-F3ADB785-DB3C-4189-BF3E-94B483CDE538Q33929673-6546237F-B368-4884-AEBB-A188B53AFDC8Q33937239-FD1490C7-03F2-465D-B97C-8FD2797C27E1Q33939688-60783176-638C-4660-939A-601E24629445Q34012451-D1A8BA43-0215-4AEF-B5E6-2AE763D1617AQ34041689-679BC8D3-14F7-46A8-9301-A6411AFABDBDQ34082383-49DC2B85-0D85-46E7-8EC2-F435B328A5CAQ34114943-1A8B8208-BDA7-4AF9-8B50-F580F5A89C24Q34199333-D4859C6B-F5FB-4C15-B175-6FE6F30C776FQ34307240-DAEA867F-CD7F-4C4F-8EA7-435E10D8DEE2Q34410874-1D383E05-C96D-4C8E-826F-4C7F07BD2855Q34441081-69D0ACFF-559B-4F75-8A0B-EF950E50FB9BQ34568113-25D2DF0F-BB38-4939-958A-9A89A3F6F584Q34602535-7E8A8916-23F0-4D5E-816B-C25F6BAC4BC7Q34616059-B45CE4BE-B667-43CD-A289-6351556FBC84Q34618818-66CC33C8-1CFB-4EE4-ABC8-20A0183F6DC2Q34736303-ACEB888E-A185-4FBE-8886-04CC267219D8Q34766133-B0FE4309-9E27-48CD-A5BA-9377AEE9DD65Q34877439-3B2AD06F-D2B7-4D29-96E0-24DBB1211475
P2860
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Ovarian function in premenopau ...... hemotherapy for breast cancer.
@en
type
label
Ovarian function in premenopau ...... hemotherapy for breast cancer.
@en
prefLabel
Ovarian function in premenopau ...... hemotherapy for breast cancer.
@en
P2093
P1476
Ovarian function in premenopau ...... hemotherapy for breast cancer.
@en
P2093
P304
P356
10.1200/JCO.1996.14.5.1718
P407
P577
1996-05-01T00:00:00Z